ABUS vs CNOBP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 26, 2026

ABUS

38.1
AI Score
VS
CNOBP Wins

CNOBP

65.8
AI Score

Investment Advisor Scores

ABUS

38score
Recommendation
SELL

CNOBP

66score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS CNOBP Winner
Net Income -33.50M 79.49M CNOBP
ROE -43.7% 4.9% CNOBP
ROA -35.4% 0.6% CNOBP
Total Assets 94.62M 14.41B CNOBP
Cash 18.01M 362.28M CNOBP

Relative Price Performance (Last 90 Days)

ABUS 1M: +17.9% · 3M: +12.1% CNOBP 1M: -0.2% · 3M: +1.4%

Current Technical Phase

ABUS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 67

RSI (14): 66.6 · Price: $5.20

CNOBP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.8 · Price: $25.11

Fundamentals Snapshot

Metric ABUS CNOBP
Market Cap
Forward P/E -46.9 0.0
Trailing P/E 6.6 8.0
Revenue (TTM)
Revenue Growth -0.9% 1.3%
Gross Margin 0.9% 1.0%
Operating Margin -5.7% 0.6%
EPS 0.79 3.15
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNOBP is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.